NO305165B1 - 1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse derav - Google Patents
1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse deravInfo
- Publication number
- NO305165B1 NO305165B1 NO954542A NO954542A NO305165B1 NO 305165 B1 NO305165 B1 NO 305165B1 NO 954542 A NO954542 A NO 954542A NO 954542 A NO954542 A NO 954542A NO 305165 B1 NO305165 B1 NO 305165B1
- Authority
- NO
- Norway
- Prior art keywords
- pct
- optionally substituted
- alkyl
- sec
- arylcycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939309749A GB9309749D0 (en) | 1993-05-12 | 1993-05-12 | Therapeutic agents |
| PCT/EP1994/001494 WO1994026704A1 (en) | 1993-05-12 | 1994-05-07 | 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO954542D0 NO954542D0 (no) | 1995-11-10 |
| NO954542L NO954542L (no) | 1996-01-10 |
| NO305165B1 true NO305165B1 (no) | 1999-04-12 |
Family
ID=10735317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO954542A NO305165B1 (no) | 1993-05-12 | 1995-11-10 | 1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse derav |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5652271A (sv) |
| EP (1) | EP0715620B1 (sv) |
| JP (2) | JP3606326B2 (sv) |
| KR (1) | KR100295264B1 (sv) |
| AT (1) | ATE172719T1 (sv) |
| AU (1) | AU681669B2 (sv) |
| BG (1) | BG61913B1 (sv) |
| BR (2) | BR9406577A (sv) |
| CZ (1) | CZ290711B6 (sv) |
| DE (1) | DE69414264T2 (sv) |
| DK (1) | DK0715620T3 (sv) |
| ES (1) | ES2124411T3 (sv) |
| FI (1) | FI955429A (sv) |
| GB (1) | GB9309749D0 (sv) |
| HU (1) | HU211124A9 (sv) |
| IL (1) | IL109635A (sv) |
| LV (1) | LV11320A (sv) |
| MY (1) | MY110773A (sv) |
| NO (1) | NO305165B1 (sv) |
| NZ (1) | NZ266776A (sv) |
| PH (1) | PH30418A (sv) |
| PL (1) | PL176400B1 (sv) |
| RO (1) | RO115519B1 (sv) |
| RU (1) | RU2135467C1 (sv) |
| SK (1) | SK281257B6 (sv) |
| TW (1) | TW318833B (sv) |
| UA (1) | UA42722C2 (sv) |
| WO (1) | WO1994026704A1 (sv) |
| ZA (1) | ZA943241B (sv) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19518988A1 (de) * | 1995-05-29 | 1996-12-05 | Basf Ag | Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit |
| GB9524681D0 (en) | 1995-12-02 | 1996-01-31 | Knoll Ag | Chemical process |
| GB9915617D0 (en) | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| US20030224045A1 (en) * | 2002-05-29 | 2003-12-04 | Chien-Hsuan Han | Combination immediate release sustained release levodopa/carbidopa dosage forms |
| US20040166159A1 (en) * | 2002-05-29 | 2004-08-26 | Chien-Hsuan Han | Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa |
| US20060013875A1 (en) * | 2002-05-29 | 2006-01-19 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| US7094427B2 (en) * | 2002-05-29 | 2006-08-22 | Impax Laboratories, Inc. | Combination immediate release controlled release levodopa/carbidopa dosage forms |
| SI2011796T1 (sl) * | 2006-04-26 | 2015-02-27 | Toyama Chemical Co., Ltd. | Induktor nevrogeneze ali terapevtska uäśinkovina proti nevropatiji, vsebujoäśa derivat alkilnega etra ali sol le-tega |
| US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| EP3054929B1 (en) | 2013-10-07 | 2020-08-05 | Impax Laboratories, LLC | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
| US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52768B1 (en) * | 1981-04-06 | 1988-02-17 | Boots Co Ltd | 1-arylcyclobutylalkylamine compounds useful as therapeutic agents |
| IE56000B1 (en) * | 1982-09-30 | 1991-03-13 | Boots Co Plc | 1-arylcyclobutylalkylamine compounds |
| GB8501192D0 (en) * | 1985-01-17 | 1985-02-20 | Boots Co Plc | Therapeutic agents |
| GB8704777D0 (en) * | 1987-02-28 | 1987-04-01 | Boots Co Plc | Medical treatment |
-
1993
- 1993-05-12 GB GB939309749A patent/GB9309749D0/en active Pending
-
1994
- 1994-05-07 JP JP52494694A patent/JP3606326B2/ja not_active Expired - Lifetime
- 1994-05-07 EP EP94916944A patent/EP0715620B1/en not_active Expired - Lifetime
- 1994-05-07 AT AT94916944T patent/ATE172719T1/de active
- 1994-05-07 NZ NZ266776A patent/NZ266776A/en not_active IP Right Cessation
- 1994-05-07 DK DK94916944T patent/DK0715620T3/da active
- 1994-05-07 ES ES94916944T patent/ES2124411T3/es not_active Expired - Lifetime
- 1994-05-07 US US08/545,752 patent/US5652271A/en not_active Expired - Lifetime
- 1994-05-07 AU AU68433/94A patent/AU681669B2/en not_active Expired
- 1994-05-07 DE DE69414264T patent/DE69414264T2/de not_active Expired - Lifetime
- 1994-05-07 RO RO95-01958A patent/RO115519B1/ro unknown
- 1994-05-07 CZ CZ19952936A patent/CZ290711B6/cs not_active IP Right Cessation
- 1994-05-07 SK SK1407-95A patent/SK281257B6/sk not_active IP Right Cessation
- 1994-05-07 KR KR1019950705037A patent/KR100295264B1/ko not_active IP Right Cessation
- 1994-05-07 BR BR9406577A patent/BR9406577A/pt not_active Application Discontinuation
- 1994-05-07 PL PL94311628A patent/PL176400B1/pl unknown
- 1994-05-07 UA UA95114926A patent/UA42722C2/uk unknown
- 1994-05-07 WO PCT/EP1994/001494 patent/WO1994026704A1/en active IP Right Grant
- 1994-05-07 RU RU95122740A patent/RU2135467C1/ru active
- 1994-05-11 ZA ZA943241A patent/ZA943241B/xx unknown
- 1994-05-12 MY MYPI94001186A patent/MY110773A/en unknown
- 1994-05-12 IL IL109635A patent/IL109635A/en not_active IP Right Cessation
- 1994-05-12 PH PH48262A patent/PH30418A/en unknown
- 1994-11-11 TW TW083110470A patent/TW318833B/zh active
-
1995
- 1995-06-30 HU HU95P/P00686P patent/HU211124A9/hu unknown
- 1995-11-10 FI FI955429A patent/FI955429A/sv unknown
- 1995-11-10 NO NO954542A patent/NO305165B1/no not_active IP Right Cessation
- 1995-11-10 BG BG100127A patent/BG61913B1/bg unknown
- 1995-12-11 LV LV950366A patent/LV11320A/xx unknown
-
1997
- 1997-04-22 BR BR1100306-5A patent/BR1100306A/pt active IP Right Grant
-
2004
- 2004-06-16 JP JP2004178477A patent/JP2004331669A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2734816B1 (fr) | Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FI952204A (sv) | Terapeutiska ämnen | |
| NO994452D0 (no) | Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse | |
| MX9708621A (es) | AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS. | |
| NO305165B1 (no) | 1-Arylcykloalkylsulfider, -sulfoksyder og -sulfoner, farmas°ytiske preparater og anvendelse derav | |
| FI961630A0 (sv) | Terapeutiska ämnen | |
| GR3033786T3 (en) | Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof | |
| KR940005534A (ko) | 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제 | |
| CA2192555A1 (en) | 2-acylaminopropanol compound and medicinal composition | |
| LV11323A (lv) | Izohinolina atvasinajumi ka arstnieciskie lidzekli | |
| ATE173471T1 (de) | Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel | |
| KR930703013A (ko) | 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제 | |
| JO1809B1 (en) | Therapeutic agents | |
| CA2162706A1 (en) | 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease | |
| ES2116880A1 (es) | Farmacos y composiciones farmaceuticas para su uso en el tratamiento de enfermedades. | |
| PT1282625E (pt) | Benzoxazinas para utilizacao no tratamento da doenca de parkinson | |
| ES2149216T3 (es) | Utilizacion de derivados de piperazina para el tratamiento de trastornos cognoscitivos. | |
| AU4544096A (en) | New derivatives of glycylanilides, preparation and therapeutical application | |
| MX9708618A (es) | AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS. | |
| NO951798D0 (no) | Terapeutiske midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |